• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球消除宫颈癌倡议。

Worldwide initiatives to eliminate cervical cancer.

作者信息

Wilailak Sarikapan, Kengsakul Malika, Kehoe Sean

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Department of Obstetrics and Gynecology, Panyananthaphikkhu Chonprathan Medical Center, Srinakharinwirot University, Nonthaburi, Thailand.

出版信息

Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):102-106. doi: 10.1002/ijgo.13879.

DOI:10.1002/ijgo.13879
PMID:34669201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9298014/
Abstract

In 2020, more than 600 000 women were diagnosed with cervical cancer and 342 000 women died worldwide. Without comprehensive control, rates of cervical cancer incidence and mortality are expected to worsen. In 2020, the World Health Organization adopted the global strategy to eliminate cervical cancer to the threshold of four cases per 100 000 women within the 21st century, using a triple pillar intervention strategy comprising 90% of girls fully vaccinated by the age of 15 years, 70% of women screened by the age of 35 years and again by 45 years, and 90% of women with precancer treated and 90% of women with invasive cancer managed. In countries with high cervical cancer incidence, a tremendous effort will be needed to overcome the challenges. This article discusses the efforts in place to accelerate achievement of this ambitious goal.

摘要

2020年,全球有超过60万女性被诊断出患有宫颈癌,34.2万女性死于宫颈癌。若不进行全面防控,宫颈癌的发病率和死亡率预计还会恶化。2020年,世界卫生组织通过了消除宫颈癌的全球战略,目标是在21世纪将宫颈癌发病率降至每10万名女性中4例的阈值,采用三支柱干预策略,即90%的女孩在15岁前完成全程接种疫苗,70%的女性在35岁时接受筛查,并在45岁时再次筛查,90%的癌前病变女性得到治疗,90%的浸润性癌女性得到妥善管理。在宫颈癌高发国家,需要付出巨大努力来克服这些挑战。本文讨论了为加速实现这一宏伟目标所做出的努力。

相似文献

1
Worldwide initiatives to eliminate cervical cancer.全球消除宫颈癌倡议。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):102-106. doi: 10.1002/ijgo.13879.
2
Eliminating Cervical Cancer: Progress and Challenges for High-income Countries.消除宫颈癌:高收入国家的进展和挑战。
Clin Oncol (R Coll Radiol). 2021 Sep;33(9):550-559. doi: 10.1016/j.clon.2021.06.013. Epub 2021 Jul 24.
3
Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control.坦桑尼亚消除宫颈癌:在地方性 HIV 感染和积极控制 HIV 的背景下消除宫颈癌的建模分析。
Int J Cancer. 2021 Jul 15;149(2):297-306. doi: 10.1002/ijc.33533. Epub 2021 Mar 24.
4
Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.到 2100 年的预测以及中国消除宫颈癌的预算优化策略:一项建模研究。
Lancet Public Health. 2019 Sep;4(9):e462-e472. doi: 10.1016/S2468-2667(19)30162-8.
5
The projected timeframe until cervical cancer elimination in Australia: a modelling study.澳大利亚消除宫颈癌的预计时间框架:建模研究。
Lancet Public Health. 2019 Jan;4(1):e19-e27. doi: 10.1016/S2468-2667(18)30183-X. Epub 2018 Oct 2.
6
Modelling the impact of prevention strategies on cervical cancer incidence in South Africa.建模预防策略对南非宫颈癌发病率的影响。
Int J Cancer. 2021 Oct 15;149(8):1564-1575. doi: 10.1002/ijc.33716. Epub 2021 Jul 19.
7
Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.针对 HPV 疫苗接种女性的宫颈癌筛查策略调整:分层指南的价值。
Eur J Cancer. 2018 Mar;91:68-75. doi: 10.1016/j.ejca.2017.12.018. Epub 2018 Jan 12.
8
COVID-19 as a catalyst for reimagining cervical cancer prevention.新冠疫情作为重新构想宫颈癌预防的催化剂。
Elife. 2023 Apr 18;12:e86266. doi: 10.7554/eLife.86266.
9
The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: A modelling study.坦桑尼亚艾滋病毒预防和控制对 HPV 和宫颈癌的过去、现在和未来影响:建模研究。
PLoS One. 2020 May 6;15(5):e0231388. doi: 10.1371/journal.pone.0231388. eCollection 2020.
10
Cancer of the cervix uteri: 2021 update.子宫颈癌:2021 年更新。
Int J Gynaecol Obstet. 2021 Oct;155 Suppl 1(Suppl 1):28-44. doi: 10.1002/ijgo.13865.

引用本文的文献

1
Strategic approaches for global cervical cancer elimination: An update review and call for national action.全球消除宫颈癌的战略方法:最新综述与呼吁国家行动
Int J Gynaecol Obstet. 2025 Sep;171 Suppl 1:120-128. doi: 10.1002/ijgo.70276.
2
Uptake of cervical cancer screening and its determinants in Africa: Umbrella review.非洲宫颈癌筛查的接受情况及其决定因素:综合综述。
PLoS One. 2025 Jul 21;20(7):e0328103. doi: 10.1371/journal.pone.0328103. eCollection 2025.
3
Prevalence of HPV, cytological abnormalities, and impact of the HPV vaccine in Mexico: a Nationwide Study of 596,944 women.墨西哥人乳头瘤病毒(HPV)的流行率、细胞学异常情况及HPV疫苗的影响:一项对596,944名女性的全国性研究
Lancet Reg Health Am. 2025 Jun 25;48:101156. doi: 10.1016/j.lana.2025.101156. eCollection 2025 Aug.
4
Assessing the role of cervical cancer awareness in shaping attitudes toward the disease among Palestinian women.评估宫颈癌认知在塑造巴勒斯坦女性对该疾病态度方面的作用。
Sci Rep. 2025 Jul 1;15(1):21530. doi: 10.1038/s41598-025-08068-1.
5
Exploring the Potential of a Novel Oil Blend Therapy for Immunity Enhancement and Cervical Carcinoma Treatment.探索一种新型混合油疗法在增强免疫力和治疗宫颈癌方面的潜力。
Asian Pac J Cancer Prev. 2025 Jun 1;26(6):2129-2136. doi: 10.31557/APJCP.2025.26.6.2129.
6
Strategies to accelerate cervical cancer elimination in Greece: a modeling study.希腊加速消除宫颈癌的策略:一项建模研究
Front Oncol. 2025 May 27;15:1480942. doi: 10.3389/fonc.2025.1480942. eCollection 2025.
7
Barriers in the prevention and early detection of human papillomavirus in Latin America.拉丁美洲人乳头瘤病毒预防与早期检测中的障碍。
Int J Gynaecol Obstet. 2025 Sep;170(3):1144-1152. doi: 10.1002/ijgo.70177. Epub 2025 Apr 22.
8
Utilization of screening services on cervical cancer and associated factors among female health workers in Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴女性卫生工作者宫颈癌筛查服务的利用情况及相关因素
PLoS One. 2025 Apr 21;20(4):e0321662. doi: 10.1371/journal.pone.0321662. eCollection 2025.
9
Factors that contribute to women's reluctance to undergo cervical cancer screening in clinics of Limpopo Province, South Africa.导致南非林波波省诊所中女性不愿接受宫颈癌筛查的因素。
BMC Public Health. 2025 Apr 7;25(1):1303. doi: 10.1186/s12889-025-22524-7.
10
Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus Agents.抗人乳头瘤病毒制剂预防宫颈癌的进展
Cancer Med. 2025 Apr;14(7):e70847. doi: 10.1002/cam4.70847.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Methodologies of Primary HPV Testing Currently Applied for Cervical Cancer Screening.目前应用于宫颈癌筛查的原发性人乳头瘤病毒检测方法
Life (Basel). 2020 Nov 19;10(11):290. doi: 10.3390/life10110290.
3
Experiences in the prevention and screening of cervical cancer within Thailand.泰国在宫颈癌预防和筛查方面的经验。
Int J Gynaecol Obstet. 2021 Jan;152(1):48-52. doi: 10.1002/ijgo.13481.
4
Cervical cancer: a meta-analysis, therapy and future of nanomedicine.宫颈癌:纳米医学的荟萃分析、治疗与未来
Ecancermedicalscience. 2020 Sep 24;14:1111. doi: 10.3332/ecancer.2020.1111. eCollection 2020.
5
CyclinA1 Promoter Methylation in Self-Sampling Test.细胞周期蛋白 A1 启动子甲基化的自我采样检测。
Asian Pac J Cancer Prev. 2020 Oct 1;21(10):2913-2917. doi: 10.31557/APJCP.2020.21.10.2913.
6
Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries.55 个中低收入国家宫颈癌筛查终身流行率。
JAMA. 2020 Oct 20;324(15):1532-1542. doi: 10.1001/jama.2020.16244.
7
Cervical Cancer Screening Uptake and Associated Factors among HIV-Positive Women in Ethiopia: A Systematic Review and Meta-Analysis.埃塞俄比亚HIV阳性女性的宫颈癌筛查接受情况及相关因素:一项系统评价与荟萃分析
Adv Prev Med. 2020 Aug 17;2020:7071925. doi: 10.1155/2020/7071925. eCollection 2020.
8
Cervical cancer in low and middle-income countries.低收入和中等收入国家的宫颈癌
Oncol Lett. 2020 Sep;20(3):2058-2074. doi: 10.3892/ol.2020.11754. Epub 2020 Jun 19.
9
Detection of Alpha, Beta, Gamma, and Unclassified Human Papillomaviruses in Cervical Cancer Samples From Mexican Women.在墨西哥女性宫颈癌样本中检测α、β、γ和未分类的人乳头瘤病毒
Front Cell Infect Microbiol. 2020 Jun 9;10:234. doi: 10.3389/fcimb.2020.00234. eCollection 2020.
10
Maximising the potential of HPV vaccines.最大化人乳头瘤病毒疫苗的潜力。
Lancet Glob Health. 2020 Apr;8(4):e460-e461. doi: 10.1016/S2214-109X(20)30073-5.